Your browser doesn't support javascript.
loading
Retinoblastoma Expression and Targeting by CDK4/6 Inhibitors in Small Cell Lung Cancer.
Wildey, Gary; Shay, Ashley M; McColl, Karen S; Yoon, Suzy; Shatat, Mohammad A; Perwez, Ahmad; Spainhower, Kyle B; Kresak, Adam M; Lipka, MaryBeth; Yang, Michael; Behtaj, Mohadese; Fu, Pingfu; Alahmadi, Asrar; Mneimneh, Wadad; Abbas, Ata; Dowlati, Afshin.
Afiliación
  • Wildey G; Division of Hematology and Oncology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
  • Shay AM; Division of Hematology and Oncology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
  • McColl KS; Division of Hematology and Oncology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
  • Yoon S; Division of Hematology and Oncology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
  • Shatat MA; Division of Pulmonary and Critical Care Medicine, Cleveland VA Medical Center, Cleveland, Ohio.
  • Perwez A; Division of Hematology and Oncology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
  • Spainhower KB; Division of Hematology and Oncology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
  • Kresak AM; Division of Pathology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
  • Lipka M; Division of Hematology and Oncology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
  • Yang M; Division of Pathology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
  • Behtaj M; Division of Pathology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
  • Fu P; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio.
  • Alahmadi A; Division of Hematology and Oncology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
  • Mneimneh W; Division of Pathology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
  • Abbas A; Division of Hematology and Oncology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
  • Dowlati A; Division of Hematology and Oncology, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, Ohio.
Mol Cancer Ther ; 22(2): 264-273, 2023 02 01.
Article en En | MEDLINE | ID: mdl-36399634
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Retinoblastoma / Neoplasias de la Retina / Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Retinoblastoma / Neoplasias de la Retina / Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos